Quince Therapeutics Inc
Quince Therapeutics Inc (QNCX) Covered Calls
No qualifying covered call setups were found for QNCX in the prior session.
Read more
Running QNCX covered calls helps you generate consistent income from Quince Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Quince Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best QNCX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if QNCX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling QNCX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Quince Therapeutics Inc covered call is worth writing.
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Income-focused investors, long-term QNCX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling QNCX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Quince Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile9.13% Subdued
- Market cap (M$)7
- 52 weeks high-97.32%
- 52 weeks low52.50%
- Analyst recommendationHold
3.40 - Target price$55.00
77.42% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-05-12
- P/E—
- Future P/E—
- EPS (ttm)-16.43
- EPS growth next 5 years—
As of September 25, 2026
No illustrative rows to display.
As of September 25, 2026
Sell covered calls with the data behind you
Find the best QNCX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→